Protective effect of tetrahydrocoptisine against ethanol-induced gastric ulcer in mice

Toxicology and Applied Pharmacology

Volumn 272, Issue 1, 2013, Pages 21-29

  Li, Weifeng ^a   Huang, Huimin ^a   Niu, Xiaofeng ^a   Fan, Ting ^a   Mu, Qingli ^a   Li, Huani ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Gastric ulcer; Myeloperoxidase; Nitric oxide; Nuclear factor B; Pro inflammatory cytokines; Tetrahydrocoptisine

Indexed keywords

ALCOHOL; CIMETIDINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MYELOPEROXIDASE; NITRIC OXIDE; STYLOPINE; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; STOMACH MUCOSA; STOMACH ULCER;

AMINOBUTYRIC ACID; CNOS; CONSTITUTIVE NO SYNTHASE; COX-2; CYCLOOXYGENASE-2; ELISA; GABAA; GASTRIC ULCER; IL-1; IL-1Β; IL-6; INDUCIBLE NO SYNTHASE; INOS; INTERLEUKIN (IL)-1Β; INTERLEUKIN-1; INTERLEUKIN-6; MPO; MYELOPEROXIDASE; NF-ΚB; NITRIC OXIDE; NO; NUCLEAR FACTOR KAPPA B; NUCLEAR FACTOR-ΚB; PGE2; PRO-INFLAMMATORY CYTOKINES; PROSTAGLANDIN E2; TETRAHYDROCOPTISINE; THC; THE ENZYME-LINKED IMMUNOSORBENT ASSAY; TLRS; TNF; TNF-Α; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALS; BERBERINE ALKALOIDS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CYTOKINES; ETHANOL; GASTRIC MUCOSA; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MICE; NITRIC OXIDE; PEROXIDASE; STOMACH ULCER; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84882782813     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.05.035     Document Type: Article

References (47)

1. Allavena P., Garlanda C., Borrello M.G., Sica A., Mantovani A. Pathways connecting inflammation and cancer. Curr. Opin. Genet. Dev. 2008, 18:3-10.
2. Appleyard C., McCafferty D., Tigley A., Swain M., Wallace J. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am. J. Physiol. Gastrointest. Liver Physiol. 1996, 270:G42-G48.
3. Beck P.L., Xavier R., Lu N., Nanda N.N., Dinauer M., Podolsky D.K., Seed B. Mechanisms of NSAID-induced gastrointestinal injury defined using mutant mice. Gastroenterology 2000, 119:699-705.
4. Brucker M.C., Faucher M.A. Pharmacologic management of common gastrointestinal health problems in women. J. Nurse Midwifery 1997, 42:145-162.
5. Chatterjee M., Saluja R., Kanneganti S., Chinta S., Dikshit M. Biochemical and molecular evaluation of neutrophil NOS in spontaneously hypertensive rats. Mol. Cell. Biol. 2007, 53:84-93.
6. Chen F., Castranova V., Shi X. New insights into the role of nuclear factor-κB in cell growth regulation. Am. J. Pathol. 2001, 159:387-397.
7. Choi J.I., Raghavendran H.R.B., Sung N.Y., Kim J.H., Chun B.S., Ahn D.H., Choi H.S., Kang K.W., Lee J.W. Effect of fucoidan on aspirin-induced stomach ulceration in rats. Chem. Biol. Interact. 2010, 183:249-254.
8. Costa N.R.D., Silva R.O., Nicolau L.A.D., Lucetti L.T., Santana A.P.M., Aragão K.S., Soares P.M.G., Ribeiro R.A., Souza M.H.L.P., Barbosa A.L.R., Medeiros J.-V.R. Role of soluble guanylate cyclase activation in the gastroprotective effect of the HO-1/CO pathway against alendronate-induced gastric damage in rats. Eur. J. Pharmacol. 2013, 700:51-59.
9. Elliott S.N., Wallace J.L. Neutrophil-mediated gastrointestinal injury. Can. J. Gastroenterol. 1998, 12:559-568.
10. Franke A., Teyssen S., Singer M.V. Alcohol-related diseases of the esophagus and stomach. Dig. Dis. 2005, 23:204-213.
11. Ghosh S. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16:225-260.
12. Gottfried E.B., Korsten M.A., Lieber C.S. Alcohol-induced gastric and duodenal lesions in man. Am. J. Gastroenterol. 1978, 70:587-592.
13. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 1982, 126:131-138.
14. Guix F., Uribesalgo I., Coma M., Munoz F. The physiology and pathophysiology of nitric oxide in the brain. Prog. Neurobiol. 2005, 76:126-152.
15. Häberlein H., Tschiersch K.-P., Boonen G., Hiller K.-O. Chelidonium majus L.: components with in vitro affinity for the GABAA receptor. Positive cooperation of alkaloids. Planta Med. 2007, 62:227-231.
16. Ham M., Kaunitz J.D. Gastroduodenal defense. Curr. Opin. Gastroenterol. 2007, 23:607-616.
17. Jang S., Kim B.H., Lee W.-Y., An S.J., Choi H.G., Jeon B.H., Chung H.-T., Rho J.-R., Kim Y.-J., Chai K.-Y. Stylopine from Chelidonium majus inhibits LPS-induced inflammatory mediators in RAW 264.7 cells. Arch. Pharm. Res. 2004, 27:923-929.
18. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 2000, 18:621-663.
19. Khan A.Q., Khan R., Rehman M.U., Lateef A., Tahir M., Ali F., Sultana S. Soy isoflavones (daidzein & genistein) inhibit 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced cutaneous inflammation via modulation of COX-2 and NF-κB in Swiss albino mice. Toxicology 2012, 302:266-274.
20. Kishimoto T., Akira S., Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science (New York, N.Y.) 1992, 258:593-597.
21. Kobayashi T., Ohta Y., Yoshino J., Nakazawa S. Teprenone promotes the healing of acetic acid-induced chronic gastric ulcers in rats by inhibiting neutrophil infiltration and lipid peroxidation in ulcerated gastric tissues. Pharmacol. Res. 2001, 43:23-30.
22. Krawisz J.E., Sharon P., Stenson W.F. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984, 87:1344-1350.
23. Kundu J.K., Surh Y.J. Inflammation: gearing the journey to cancer. Mutat. Res. 2008, 659:15-30.
24. Le J., Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Invest. 1987, 56:234-248.
25. Leon L.R., White A.A., Kluger M.J. Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1998, 275:R269-R277.
26. Lin W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 2007, 117:1175-1183.
27. Liu Y., Tian X., Gou L., Fu X., Li S., Lan N., Yin X. Protective effect of l-citrulline against ethanol-induced gastric ulcer in rats. Environ. Toxicol. Pharmacol. 2012, 34:280-287.
28. Mei X., Xu D., Xu S., Zheng Y., Xu S. Novel role of Zn(II)-curcumin in enhancing cell proliferation and adjusting proinflammatory cytokine-mediated oxidative damage of ethanol-induced acute gastric ulcers. Chem. Biol. Interact. 2012, 197:31-39.
29. Nagai N., Fukuhata T., Ito Y., Usui S., Hirano K. Involvement of interleukin 18 in indomethacin-induced lesions of the gastric mucosa in adjuvant-induced arthritis rat. Toxicology 2009, 255:124-130.
30. Nishida K., Ohta Y., Ishiguro I. Contribution of NO synthases to neutrophil infiltration in the gastric mucosal lesions in rats with water immersion restraint stress. FEBS Lett. 1998, 425:243-248.
31. Rodrigues e Silva A.A., Marques Bezerra M., Vasconcelos Chaves H., de Paulo Teixeira Pinto V., de Souza Franco E., Magalhães Vieira Â., Barbosa Araújo E., Cunha Rios L., Resende Leite A.C., de Sousa Maia M.B. Protective effect of Chresta martii extract on ethanol-induced gastropathy depends on alpha-2 adrenoceptors pathways but not on nitric oxide, prostaglandins or opioids. J. Ethnopharmacol. 2012, 142:206-212.
32. Rogler G., Andus T. Cytokines in inflammatory bowel disease. World J. Surg. 1998, 22:382-389.
33. Salga M.S., Ali H.M., Abdulla M.A., Abdelwahab S.I. Gastroprotective activity and mechanism of novel dichlorido-zinc(II)-4-(2-(5-methoxybenzylideneamino)ethyl)piperazin-1-iumphenolate complex on ethanol-induced gastric ulceration. Chem. Biol. Interact. 2012, 195:144-153.
34. Santos F., Rao V. 1,8-Cineol, a food flavoring agent, prevents ethanol-induced gastric injury in rats. Dig. Dis. Sci. 2001, 46:331-337.
35. Schultze-Osthoff K., Bakker A., Vanhaesebroeck N., Beyaert R., Jacobs W., Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J. Biol. Chem. 1992, 267:5317-5323.
36. Sherwood E.R., Toliver-Kinsky T. Mechanisms of the inflammatory response. Best Pract. Res. Clin. Anaesthesiol. 2004, 18:385-405.
37. Suzuki S., Singhirunnusorn P., Nakano H., Doi T., Saiki I., Sakurai H. Identification of TNF-alpha-responsive NF-kappaB p65-binding element in the distal promoter of the mouse serine protease inhibitor SerpinE2. FEBS Lett. 2006, 580:3257-3262.
38. Szabo S., Vattay P., Scarbrough E., Folkman J. Role of vascular factors, including angiogenesis, in the mechanisms of action of sucralfate. Am. J. Med. 1991, 91:S158-S160.
39. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 2001, 107:7-12.
40. Takeuchi K., Yasuhiro T., Asada Y., Sugawa Y. Role of nitric oxide in pathogenesis of aspirin-induced gastric mucosal damage in rats. Digestion 1998, 59:298-307.
41. Verstrepen L., Carpentier I., Verhelst K., Beyaert R. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling. Biochem. Pharmacol. 2009, 78:105-114.
42. Wallace J.L., Keenan C.M., Granger D.N. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am. J. Physiol. Gastrointest. Liver Physiol. 1990, 259:G462-G467.
43. Wise G.E., Yao S. Expression of tumour necrosis factor-alpha in the rat dental follicle. Arch. Oral Biol. 2003, 48:47-54.
44. Wu L.-c, Fan N.-c, Lin M.-h, Chu I.-r, Huang S.-j, Hu C.-Y., Han S.-y Anti-inflammatory effect of spilanthol from Spilanthes acmella on murine macrophage by down-regulating LPS-induced inflammatory mediators. J. Agric. Food Chem. 2008, 56:2341-2349.
45. Yadav S.K., Adhikary B., Chand S., Maity B., Bandyopadhyay S.K., Chattopadhyay S. Molecular mechanism of indomethacin-induced gastropathy. Free Radic. Biol. Med. 2012, 52:1175-1187.
46. Yagnik R.M., Benzeroual K.E. Tigecycline prevents LPS-induced release of pro-inflammatory and apoptotic mediators in neuronal cells. Toxicol. In Vitro 2013, 27:686-693.
47. Zou L.B., Kim Y.S. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-κB, JNK and p38 MAPK inactivation. Eur. J. Pharmacol. 2008, 586:340-349.